Singapore: Australian biotechnology company Minomic International has collaborated with US partner to develop a potentia...
Singapore: The US Food and Drug Administration (FDA) has granted Genmab and GlaxoSmithKline (GSK) breakthrough therapy d...
Singapore: According to an international multiple sclerosis (MS) registry and a US health claims database, Novartis' Gi...
Singapore: Gilead Sciences has expanded its agreement with Ireland based Janssen for the development and commercializati...
Tokyo: Shionogi, one of Japan's century-old pharmaceutical manufacturers, has announced that its once-daily naldemedine ...
Singapore: Australian pharmaceutical company Pharmaxis, and UK biotechnology company, Synairgen, have entered into a res...
Singapore: Taiwan's PharmaEngine licensing partner, Merrimack Pharmaceuticals, and its sublicensing partner, Baxter Inte...
Singapore: HUYA Bioscience International has signed an exclusive license with Fudan University for the ex-China rights t...
Singapore: Australia-based drug discovering company, Phylogica has inked a pact with US-based Genentech, to discover nov...
Singapore: Pharma giant Pfizer has received a complete response letter from the US Food and Drug Administration (FDA) o...
Singapore: Taiwan's PharmaEngine has recieved Taiwan Food and Drug Administration (TFDA) approval for ONIVYDE (irinoteca...
Singapore: Australia-based Cellmid has received patent approval from IP Australia for method of treatment or prevention ...
Singapore: Global pharmaceutical firm, Pfizer, has recieved US Food and Drug Administration (FDA) nod for review of Biol...
Singapore: US-based TNI BioTech, a biotechnology company focused on autoimmune diseases in emerging nations, has partner...
Japan Vaccine, an affiliate of pharmaceutical giant Daiichi Sankyo, and Terumo Corporation have filed an application for...
Singapore: Japanese pharmaceutical major Astellas Pharma has announced that it would cut down its group workforce in hom...
Singapore: Researchers at Montreal Heart Institute has demonstrated positive result from the medication of dalcetrapib i...
Singapore: After years of rejecting approval for Impax's flagship drug Rytary, a treatment for Parkinson's disease, the ...
